Winston Pharmaceuticals, Inc.
WPHM · OTC
3/31/2010 | 12/31/2009 | 9/30/2009 | 6/30/2009 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -6.6% | -3.3% | -4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $1 | $1 |
| G&A Expenses | $0 | $1 | $0 | $0 |
| SG&A Expenses | $0 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$0 | -$1 | -$1 | -$1 |
| % Margin | -145.7% | -165.8% | -200.5% | -188.4% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$0 | -$1 | -$1 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$1 | -$1 | -$1 |
| % Margin | -145.5% | -165.7% | -200.4% | -167.7% |
| EPS | -0.01 | 0 | -0.01 | -0.01 |
| % Growth | – | 100% | 0% | – |
| EPS Diluted | -0.01 | 0 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 77 | 0 | 57 | 55 |
| Weighted Avg Shares Out Dil | 77 | 0 | 57 | 55 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$1 | -$1 | -$1 |
| % Margin | -145.1% | -165.2% | -199.9% | -187.8% |